Mohamad, Al-shaima .

HRN: 12-22-61  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2026
OXACILLIN 500MG (VIAL)
07/30/2026
08/05/2026
IV
1gm
Q6
Dermatitis With Superimposed Bacterial Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: